Alumni-Built. Community-Driven. Hopkins to the Core.
We're an alumni-led angel network turning the world's greatest research university into a pipeline for the next generation of transformative companies.
Where the best research meets the boldest founders
Johns Hopkins is the nation's #1 research university — where groundbreaking discovery is the standard, producing transformative companies and founders for over 150 years.
1891 Angels gives members exclusive, early access to startups born from this ecosystem. We back Hopkins-affiliated founders nationwide — from faculty spinouts to alumni ventures across Baltimore, the Bay Area, New York, Boston, and beyond.
With 200+ alumni investors and growing, we're one of the most active university-tied investor communities in the country, turning Hopkins discovery into real-world impact.
Led by Hopkins alumni who've been in the room
Our partners bring deep experience across healthcare, investment banking, private equity, and venture-backed companies.
Partner at Dental Innovation Alliance managing a $70M fund. Former VP at England & Company with experience across healthcare, technology, and industrial sectors. Co-founder of Ralli. Has led and advised on over $1 billion in transactions. Holds an M.S. in Healthcare Management from Johns Hopkins University.
Healthcare operator and strategist with over a decade of experience across private equity and venture-backed companies. Currently leads product and strategy at Lucent Health. Previously at CVS Health, Sage Growth Partners, and the CDC. Holds an M.S. in Healthcare Management from Johns Hopkins University. Based in Denver.
Marcus is a student-athlete at Johns Hopkins pursuing Applied Mathematics & Statistics and Economics while competing as an offensive lineman on the football team. He supports 1891 Angels through his work with the JHU Center for Leadership Education as a HopStart intern, helping early-stage teams refine business models and investor pitches. He brings experience in legal analysis from Marin Linder Law Group and equity research from Consortium Research Group, where he focused on AI infrastructure and technology markets. Based in New Jersey.
Sarah is a 5th-year PhD candidate in the Cellular and Molecular Medicine program at the Johns Hopkins School of Medicine, where she studies early pancreatic cancer biology and genomics. She brings a rare mix of scientific depth and commercialization curiosity, supporting 1891 Angels on diligence and founder support. Excited by how great science becomes great companies.
What we believe in
The principles that guide every decision we make, from which founders we back to how we support them after the check.
Passion for innovation
Championing the relentless pursuit of breakthrough ideas that change industries and improve lives.
Community impact
Creating real opportunities for founders and startups to thrive through strategic support and mentorship.
Shaping tomorrow
Dedicated to bringing the transformative benefits of Hopkins discovery and innovation to the world.
Want to be part of the story?
Join a community of Hopkins-connected investors backing the next generation of founders, or reach out as a founder ready to build.